N-(2,1,3-benzothia(oxa)diazolyl)-sulphonamides having an endothelin receptor antagonistic effect
A Standard patent application filed on 20 February 1997 credited to Mederski, Werner
;
Osswald, Mathias
;
Christadler, Maria
;
Schmitges, Claus-Jochen
;
Wilm, Claudia
;
Dorsch, Dieter
Details
Application number :
18756
Application type :
Standard
Application status :
LAPSED
Under opposition :
No
Proceeding type :
Invention title :
N-(2,1,3-benzothia(oxa)diazolyl)-sulphonamides having an endothelin receptor antagonistic effect
Inventor :
Mederski, Werner
;
Osswald, Mathias
;
Christadler, Maria
;
Schmitges, Claus-Jochen
;
Wilm, Claudia
;
Dorsch, Dieter
Agent name :
Davies Collison Cave
Address for service :
GPO Box 3876 SYDNEY NSW 2001
Filing date :
20 February 1997
Associated companies :
Applicant name :
Merck Patent Gesellschaft Mit Beschrankter Haftung